Quince Therapeutics Inc (QNCX) News

Annual Report to Security Holders (ars)

Proxy Statement (definitive) (def 14a)

Table of Contents DEF 14Afalse0001662774 0001662774 2022-01-01 2022-12-31 0001662774 2021-01-01 2021-12-31...

Quince Therapeutics Board of Directors Unanimously Rejects Unsolicited Proposal from Echo Lake Capital

Quince Therapeutics, Inc. (Nasdaq: QNCX), a biotechnology company focused on acquiring, developing, and commercializing innovative therapeutics...

Quince Therapeutics Engages MTS Health Partners as Independent Financial Advisor

Quince Therapeutics, Inc. (Nasdaq: QNCX), a biotechnology company focused on acquiring, developing, and commercializing innovative therapeutics...

Securities Registration (section 12(b)) (8-a12b)

    UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549     FORM 8-A    ...

Quince Therapeutics Adopts Limited Duration Stockholders Rights Plan

Quince Therapeutics, Inc. (Nasdaq: QNCX), a biotechnology company focused on acquiring, developing, and commercializing innovative therapeutics...

Statement of Ownership (sc 13g)

  Securities and Exchange Commission Washington, DC 20549     SCHEDULE 13G      ...

Current Report Filing (8-k)

false 0001662774 0001662774 2023-03-27 2023-03-27     UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549  ...

Quince Therapeutics Confirms Receipt of Unsolicited Acquisition Offer from Echo Lake Capital

Quince Therapeutics, Inc. (Nasdaq: QNCX), a biotechnology company focused on acquiring, developing, and commercializing innovative therapeutics...

Another Biotech Massively Outperforms Broader Equities

It was a big day for biotechs in the penny stock space on Tuesday. Following our “Catching A Bid” article we put out during...

Securities Registration: Employee Benefit Plan (s-8)

As filed with the Securities and Exchange Commission on March 15, 2023 Registration No. 333-     &nbs...

Current Report Filing (8-k)

false 0001662774 0001662774 2023-03-01 2023-03-01     UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549  ...

Amended Statement of Ownership (sc 13g/a)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of...

Statement of Changes in Beneficial Ownership (4)

FORM 4 [ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction...

Statement of Changes in Beneficial Ownership (4)

FORM 4 [ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction...